T1	Participants 62 100	laryngopharyngeal epidermoid carcinoma
T2	Participants 136 217	Twenty-four patients, with a biopsy-proven laryngeal or hypopharyngeal carcinoma,
T3	Participants 611 650	patients with laryngo-pharyngeal cancer
